These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Fulginiti VA; Papier A; Lane JM; Neff JM; Henderson DA Clin Infect Dis; 2003 Jul; 37(2):241-50. PubMed ID: 12856217 [TBL] [Abstract][Full Text] [Related]
23. Interpreting the epidemiology of postexposure vaccination against smallpox. Nishiura H; Eichner M Int J Hyg Environ Health; 2008 Mar; 211(1-2):219-26. PubMed ID: 17321212 [TBL] [Abstract][Full Text] [Related]
24. Smallpox vaccination and bioterrorism with pox viruses. Mayr A Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):423-30. PubMed ID: 12818626 [TBL] [Abstract][Full Text] [Related]
25. Ocular complications in the Department of Defense Smallpox Vaccination Program. Fillmore GL; Ward TP; Bower KS; Dudenhoefer EJ; Grabenstein JD; Berry GK; Madigan WP Ophthalmology; 2004 Nov; 111(11):2086-93. PubMed ID: 15522376 [TBL] [Abstract][Full Text] [Related]
27. Can smallpox response teams use the experience of disease management programs? Kozma CM Manag Care Interface; 2003 Feb; 16(2):45-6. PubMed ID: 12647526 [TBL] [Abstract][Full Text] [Related]
28. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Talbot TR; Ziel E; Doersam JK; LaFleur B; Tollefson S; Edwards KM Clin Infect Dis; 2004 Feb; 38(4):536-41. PubMed ID: 14765347 [TBL] [Abstract][Full Text] [Related]
29. Clinical guidance for smallpox vaccine use in a postevent vaccination program. Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372 [TBL] [Abstract][Full Text] [Related]
31. A look behind the scenes: bioterrorism, smallpox, and public health policy. Beane J J Biolaw Bus; 2004; 7(2):40-53. PubMed ID: 15460560 [TBL] [Abstract][Full Text] [Related]
32. [Confronting bioterrorism: Epidemiologic, clinical, and preventive aspects of smallpox]. Franco-Paredes C; del Río C; Nava-Frías M; Rangel-Frausto S; Téllez I; Santos-Preciado JI Salud Publica Mex; 2003; 45(4):298-309. PubMed ID: 12974047 [TBL] [Abstract][Full Text] [Related]
34. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Wiser I; Balicer RD; Cohen D Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424 [TBL] [Abstract][Full Text] [Related]
35. Healthcare workers who elected not to receive smallpox vaccination. Wortley PM; Schwartz B; Levy PS; Quick LM; Evans B; Burke B Am J Prev Med; 2006 Mar; 30(3):258-65. PubMed ID: 16476643 [TBL] [Abstract][Full Text] [Related]
36. National preparedness for biological warfare and bioterrorism: smallpox and the ophthalmologist. Maki DG Arch Ophthalmol; 2003 May; 121(5):710-1. PubMed ID: 12742850 [No Abstract] [Full Text] [Related]
37. The next agent of terror? Understanding smallpox & its implications for prehospital crews. Brocato CE; Miller GT JEMS; 2002 Mar; 27(3):44-50, 52-5. PubMed ID: 11913182 [TBL] [Abstract][Full Text] [Related]
38. Smallpox vaccination--implications for the occupational health professional. DesRoches P AAOHN J; 2003 Jun; 51(6):240-2. PubMed ID: 12846455 [TBL] [Abstract][Full Text] [Related]
39. Smallpox vaccination after a bioterrorism-based exposure. Bicknell WJ; James K Clin Infect Dis; 2003 Aug; 37(3):467. PubMed ID: 12884184 [No Abstract] [Full Text] [Related]
40. Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel. Levy Y; Anis E; Kaliner E; Grotto I; Danon YL Vaccine; 2012 Oct; 30(47):6632-5. PubMed ID: 22963804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]